Phase I/II clinical trial will be first of its kind to explore cannabis as a potential treatment option for essential tremor.
To date, 6 U.S. states have implemented retail sales of recreational marijuana but none have been able to implement an effective training program for retailers.
Cannabis users experience increased cortical activation during the brain’s resting state when compared with nonusers which may impair brain activity and disrupt cognitive processes.
The authors behind the work believe that CBD may constitute an excellent candidate for the treatment of MS and other autoimmune diseases as a novel, non-psychoactive therapeutic.
This article highlights the areas where Illinois could make improvements in order to establish a more efficient and effective medicinal cannabis treatment program.
A clinical trial involving 20 Canadian children with severe intractable epilepsy has posted resulting indicating cannabis oil could reduce seizures by over 70%.
Self-reporting study fuels debate over the potential risks to mental health of long term, high THC concentrate use.
Study reveals sex-specific effects of prenatal cannabinoid exposure on adult offspring and identifies potential new therapeutic strategies.